Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

NCT05711719 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05711719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05711719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
June 16, 2023
Completion date
November 18, 2025
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary microvascular dysfunction, metabolic syndrome